Researchers reversed damage to the mouse eye (shown in a microscope image of a healthy animal, above) by genetically reprogramming neurons that make up the optic nerve. By Kelly ServickDec.
Researchers reversed damage to the mouse eye (shown in a microscope image of a healthy animal, above) by genetically reprogramming neurons that make up the optic nerve. By Kelly ServickDec.
Atara is a pioneer in allogeneic T-cell immunotherapy with industry-leading allogeneic cell manufacturing processes and CAR T technologies. Under the terms of the deal, that San Francisco-based innovator will receive an upfront payment of US60m, and up to a total of US$610m for development, regulatory and commercialization milestones, plus tiered royalties up to low double-digit percentage of net sales.
Abstract Remyelination failure in multiple sclerosis (MS) is associated with a migration/differentiation block of oligodendroglia. The reason for this block is highly debated
Groundbreaking research in stem cells has propelled scientists understanding of neurodegenerative diseases, including Parksinsons. Could stem cell therapies one day help cure Alzheimers
Global Induced Pluripotent Stem Cells Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application The Lexis Business Insights added a new report Global Induced Pluripotent Stem Cells Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 2024 in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting. In 2020, the global Induced Pluripotent Stem Cells Market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2020-2025. The global Induced Pluripotent Stem Cells Market report offers a complete overview of the Induced Pluripotent Stem Cells Market globally.
The global induced pluripotent stem cells (ipsc) market is estimated to surpass $2,638.5 million by 2027, exhibiting a CAGR of 7.8% from 2020 to 2027. The report aims to offer a clear picture of the current scenario and future growth of the global Induced Pluripotent Stem Cells (iPSC) market
Less than two months after life sciences giant Bayer acquired N.C.-based AskBio, a gene therapy company, the healthcare giant launched a cell and gene therapy platform within its pharmaceutical division.
As you were browsing http://www.streetinsider.com something about your browser made us think you were a bot. If you are interested in http://www.streetinsider.com content, APIs are available.
A succinct analysis of market size, regional growth and revenue projections for the coming years is presented in GlobalStem Cells Marketreport. The study further sheds light on major issues and the new growth strategies implemented by manufacturers that are part ofcompetitive landscape of the studied market.Thereport offers key trends, investment opportunities and drivers in Global Stem Cells Marketwith the latest market intelligence by adopting primary and secondary research methods.
This article was originally published here Stem Cells Transl Med. 2020 Nov 11
Recent Comments